Notify me when Denise Carter files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals Ltd. | Ordinary Shares, no par value per share (represented by American Depositary Shares) | 4.9% | $244,202 | +$82,374 | 939,238 | +51% | Denise Carter | 27 Jan 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|